Latest News about BGNE
Recent news which mentions BGNE
Assembly Biosciences Foregoes Vebicorvir Registration Studies For Chronic Suppressive Therapy
February 26, 2021
From Benzinga
The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal
February 17, 2021
From Benzinga
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts
February 11, 2021
From Benzinga
The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market
January 26, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Friday
January 22, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study
January 20, 2021
From Benzinga
The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
January 15, 2021
From Benzinga
Why BeiGene, T2 Biosystems And Amneal Are Are Moving Today
January 12, 2021
From Benzinga
The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue
January 12, 2021
From Benzinga
IPO Outlook: Popular E-commerce Company Wish, Plus Offerings From A Personal Loan Disruptor And A Biotech Firm
December 13, 2020
From Benzinga
The Daily Biotech Pulse: ASH Presentations, Axsome's Positive Midstage Readout, Follow-On Offerings
December 08, 2020
From Benzinga
Week Ahead In Biotech: FDA To Decide On Emergency Use Of Pfizer's COVID Vaccine, Hematology Conference Presentations Pick Up Pace
December 06, 2020
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Gets Temporary UK Authorization, Ovid's Trial Disappointment, Vanda Snags FDA Nod
December 02, 2020
From Benzinga
The Week Ahead In Biotech: Hematology Conference Gets Underway, Vanda And BioCryst Await FDA Decisions
November 29, 2020
From Benzinga
The Daily Biotech Pulse: Amarin Surges On Vascepa Data, Mesoblast Rallies On Novartis Deal, Decision Day For Eiger
November 20, 2020
From Benzinga
10 Biggest Price Target Changes For Thursday
November 19, 2020
From Benzinga
Benzinga's Top Upgrades, Downgrades For November 6, 2020
November 06, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Friday
October 16, 2020
From Benzinga
The Daily Biotech Pulse: J&J Pauses Coronavirus Vaccine Studies, Voyager's Huntington's Disease Study Placed On Hold, Altimmune Vaccine Data
October 13, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Monday
October 12, 2020
From Benzinga
46 Stocks Moving in Wednesday's Pre-Market Session
October 07, 2020
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Monday
October 05, 2020
From Benzinga
The Daily Biotech Pulse: Mesoblast Slumps On FDA Rejection, AstraZeneca's Breakthrough Therapy Designation, 3 IPOs
October 02, 2020
From Benzinga
The Daily Biotech Pulse: Amag Spikes On Takeover Rumors, Zosano Wilts On Regulatory Setback, Pulmonx Makes Wall Street Debut
October 01, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
September 30, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.